Sign in

NCT04068844Completed

Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

Source: ClinicalTrials.gov · Last updated 3 Jun 2026

Brief summary (registry, in English)

The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific exercise training programs (whole body vs single leg) will result in improved exercise tolerance.

Status (registry)
Completed
Study type
Interventional
Enrollment
93 (actual)
First submitted
22 Aug 2019
Start date
1 Aug 2019
Primary completion date
1 Aug 2025
Lead sponsor
University of Texas Southwestern Medical Center
NCT number
NCT04068844

What you commit to

  • Study type: Interventional
  • Participants enrolled: 93
  • From 1 Aug 2019 to the primary completion date, 1 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • PDE5 inhibitor use

Other illness

  • Severe valvular disease

Age

  • age \< 60 years

Other

  • BMI \> 50 kg/m2
  • Severe COPD
  • CKD 4 or higher
  • Contra-indication to MRI.

Who the study is looking for

  • signs and symptoms of heart failure
  • an ejection fraction \> 0.50
  • objective evidence of diastolic dysfunction

Age in the registry: 60 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Institute for Exercise and Environmental Medicine
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.